Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients

Documenti analoghi

• Virological and Immunological Characteristics of HBeAg ‐Positive Chronic Hepatitis B Patients With Low HBsAg Levels
  di: Yuxin Chen, et al.
  Pubblicazione: (2024)
• Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals
  di: Yen‐Chun Liu, et al.
  Pubblicazione: (2024)
• Favourable Prognosis of Patients With Untreated HBeAg‐Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mL
  di: Jian Wang, et al.
  Pubblicazione: (2024)
• CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance
  di: Hye Won Lee, et al.
  Pubblicazione: (2024)
• Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations. Authors' Reply
  di: Yuxin Chen, et al.
  Pubblicazione: (2025)